Parallel Advisors, LLC Cocrystal Pharma, Inc. Transaction History

Parallel Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$1.01 - $1.25 $2,020 - $2,500	-2,000 Reduced 1.08%	182,708 $192,000
Q2 2021 Aug 06, 2021	SELL	$1.08 - $2.14 $9,720 - $19,260	-9,000 Reduced 4.65%	184,708 $231,000
Q1 2021 Apr 23, 2021	SELL	$1.3 - $2.35 $11,050 - $19,975	-8,500 Reduced 4.2%	193,708 $269,000
Q4 2020 Feb 02, 2021	BUY	$0.8 - $2.16 $58,916 - $159,073	73,645 Added 57.28%	202,208 $275,000
Q1 2020 Apr 27, 2020	BUY	$0.48 - $2.19 $38,121 - $173,927	79,419 Added 161.6%	128,563 $91,000
Q4 2019 Jan 30, 2020	BUY	$0.39 - $2.05 $251 - $1,322	645 Added 1.33%	49,144 $24,000
Q3 2019 Nov 01, 2019	BUY	$1.69 - $2.88 $81,963 - $139,677	48,499 New	48,499 $99,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $17.5M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.